The next Seminar In Investigative Medicine lecture is scheduled for Tuesday, October 20 in the Goldman International Conference Center of the Feinstein Institute for Medical Research. Our guest speaker will be Brian Annex, MD, George A. Beller/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine, professor of Medicine and Biomedical Engineering, chief of the Division of Cardiovascular Medicine at University of Virginia. Dr. Annex will be presenting, “Translational Research in Angiogenesis/Peripheral Arterial Disease: A Vascular Biology Approach Toward New Therapies”. He will be hosted by Peter Berger, MD.
Goal: The overall goal for the RSC (Regularly Scheduled Conference) is to inform physicians of new developments in understanding basic mechanisms of disease and novel therapeutics that capitalize on a deeper appreciation of disease pathophysiology.
Program Objectives: Upon completion of this session, participants should be able to:
- Identify new developments in understanding mechanisms of disease.
- Integrate new investigational results with current diagnostic and treatment protocols.
- Judge the potential importance for current best practices of treatment regimes based on new translational studies
Target Audience: Researchers, Students, Hospital-based physicians, Housestaff, Nurses, and Community physicians.
CME ACCREDITATION: North Shore-LIJ Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT: The North Shore-LIJ Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Each physician should only claim credit commensurate with the extent of their participation in the activity.
DISCLOSURE POLICY: North Shore-LIJ Health System adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by North Shore-LIJ for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.
Planner and Speaker’s Disclosures:
Thomas L. Rothstein, MD, PhD, course director, and Bettie Steinberg, PhD, RSS planner, have no financial relationship to disclose. Brian Annex, MD receives compensation from AnGes MG, Astra-Zeneca, BioCat , Cellgene, Diacchi, and Takeda as scientific advisor. Dr Annex also has ownership interest in Theravasc as part owner and scientific advisor.
Recognition of Program Support: An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.
The post Seminar In Investigative Medicine with Brian Annex, MD appeared first on The Feinstein Institute for Medical Research.
